Zobrazeno 1 - 10
of 242
pro vyhledávání: '"Barry Bresnihan"'
Autor:
Ceara E Walsh, Elizabeth J Ryan, Cliona O'Farrelly, Lucy Golden-Mason, Oliver FitzGerald, Douglas J Veale, Barry Bresnihan, Ursula Fearon
Publikováno v:
PLoS ONE, Vol 6, Iss 11, p e27182 (2011)
ObjectiveTNF inhibitors (TNFi) have revolutionised the treatment of rheumatoid arthritis (RA). Natural killer (NK) cells and Natural Killer Cell Receptor+ T (NKT) cells comprise important effector lymphocytes whose activity is tightly regulated throu
Externí odkaz:
https://doaj.org/article/26294b28a0c041b9b489ec5455461129
Autor:
Douglas J. Veale, Oliver FitzGerald, Anders Ringnér, Gabrielle McKee, Barry Bresnihan, Patricia Minnock
Publikováno v:
Musculoskeletal Care. 15:23-35
Introduction: Fatigue is a major symptom of rheumatoid arthritis (RA), the most common chronic inflammatory joint disease. The present study explored patients' experiences of RA fatigue to elucidat ...
Autor:
Patricia, Minnock, Anders, Ringnér, Barry, Bresnihan, Douglas, Veale, Oliver, FitzGerald, Gabrielle, McKee
Publikováno v:
Musculoskeletal care. 15(1)
Fatigue is a major symptom of rheumatoid arthritis (RA), the most common chronic inflammatory joint disease. The present study explored patients' experiences of RA fatigue to elucidate unique elements and management strategies.This single site study
Autor:
Roisin Adams, Barry Bresnihan, Michael J. Barry, Cathal Walsh, Douglas J. Veale, Oliver FitzGerald, Benjamin M. Craig
Publikováno v:
Value in Health. 14(6):921-927
Background and Objective It is well established that there are problems with the EQ-5D. This is due to the original scoring methods used and how negative time trade-off (TTO) values were treated. A revised scoring method has been published. This arti
Autor:
Ursula Fearon, Mary Connolly, Ronan H Mullan, Mark Blades, Paola Maderna, Douglas J. Veale, Barry Bresnihan, Catherine Godson, Alessandra Marrelli, J. McCormick, Costantino Pitzalis, Oliver FitzGerald
Publikováno v:
The Journal of Immunology. 184:6427-6437
Serum amyloid A (A-SAA), an acute-phase protein with cytokine-like properties, is expressed at sites of inflammation. This study investigated the effects of A-SAA on chemokine-regulated migration and angiogenesis using rheumatoid arthritis (RA) cells
Autor:
Michael J. Barry, Douglas J. Veale, Barry Bresnihan, Roisin Adams, Cathal Walsh, Oliver FitzGerald
Publikováno v:
PharmacoEconomics. 28:477-487
Background: The growth of economic analyses and in particular cost-utility analyses (CUA), which use the QALY as a measure of outcome, has heightened the interest in the methodologies used to calculate the QALY. The EQ-5D has produced quite different
Autor:
Cormac T. Taylor, Monika Biniecka, Donal J. Buggy, Jacintha O'Sullivan, Ursula Fearon, Douglas J. Veale, J. McCormick, Oliver FitzGerald, Aisling Kennedy, Chin Teck Ng, Barry Bresnihan
Publikováno v:
Annals of the Rheumatic Diseases
Hypoxia is a microenvironmental feature in the inflamed joint, which promotes survival advantage for cells. The aim of this study was to examine the relationship of partial oxygen pressure in the synovial tissue (tPO(2)) in patients with inflammatory
Autor:
Barry Bresnihan, Mary Connolly, Ursula Fearon, J. McCormick, Douglas J. Veale, Ronan H Mullan
Publikováno v:
The American Journal of Pathology. 176:1999-2008
Acute phase apoprotein Serum Amyloid A (A-SAA), which is strongly expressed in rheumatoid arthritis synovial membrane (RA SM), induces angiogenesis, adhesion molecule expression, and matrix metalloproteinase production through the G-coupled receptor
Publikováno v:
International Journal of Therapy and Rehabilitation. 17:24-33
Aims This article details a qualitative study aiming to explore the impact of rheumatoid arthritis (RA) on participation in paid work during the first two years after diagnosis. Methods In-depth semi-structured interviews using the Model of Human Occ
CCR5 blockade in rheumatoid arthritis: a randomised, double-blind, placebo-controlled clinical trial
Autor:
Arno W R, van Kuijk, Clarissa E, Vergunst, Danielle M, Gerlag, Barry, Bresnihan, Juan J, Gomez-Reino, Regine, Rouzier, Patrick C, Verschueren, Christiaan, van der Leij, Christiaan, van de Leij, Mario, Maas, Maarten C, Kraan, Paul P, Tak
Publikováno v:
Annals of the rheumatic diseases, 69(11), 2013-2016. BMJ Publishing Group
Annals of the Rheumatic Diseases, 69(11), 2013-2016. BMJ Publishing Group
Annals of the Rheumatic Diseases, 69(11), 2013-2016. BMJ Publishing Group
ObjectiveC-C chemokine receptor type 5 (CCR5), a chemokine receptor expressed on T cells and macrophages, and its ligands are found in inflamed synovial tissue (ST) of patients with rheumatoid arthritis (RA). The rationale for testing CCR5 blockade i